| [1] |
KE Xiuqin, HAI Xuewu.
433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927.
|
| [2] |
GUO Wen, DENG Zhijian, ZHANG Yongheng, GUO Jinhui.
One Case of Atrial Fibrillation Caused by Terazosin Tablets
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 580-582.
|
| [3] |
LIU Ying, GUO Hongye, YANG Yiheng, JIN Rui.
One Case of Hematological Abnormalities Caused by Lipoic Acid Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 456-459.
|
| [4] |
NI Wenqi, ZHU Feng, ZHOU Shuang, CUI Yimin.
Research Progress in Drug-Induced Hypotension
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 475-480.
|
| [5] |
WANG Songlan, SUN Ying, CHEN Aiqun, JI Liwei.
One Case of Acute Kidney Injury Induced by Evolocumab Injection in a Patient with Chronic Kidney Disease after Renal Transplantation
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 221-223.
|
| [6] |
ZHAO Qiuyue, WEI Hongtao, LI Dandan, YAN An, DI Xuan.
Adverse Reactions of Argatroban in the Treatment of Ischemic Stroke Leading to Gastrointestinal Bleeding
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 88-92.
|
| [7] |
MENG Kangkang, TANG Ren.
Risks of Calcium Dobesilate Preparations to Safety
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1288-1292.
|
| [8] |
ZHANG Jing, ZHANG Kai, YI Zhanmiao.
Efficacy and safety of salvianolic acid preparations for adjuvant therapy on related diseases of coronary heart disease, angina and cerebral infarction: a systematic review
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 910-915.
|
| [9] |
WANG Yuxi, ZHANG Zonglin, WANG Yingli, CHEN Yafei, LI Junsheng, HUO Yanfei, XIE Yanjun, LIU Wenqi.
560 cases of adverse drug reaction/event caused by Mailu Shutong pills
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 921-924.
|
| [10] |
ZHAO Jun, DONG li, WANG Yang, LIANG Yu, YANG Xue, LI Enze.
Adverse reaction/event reports of esmolol
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 925-930.
|
| [11] |
LI Fang, LONG Xiuying, BAI Na, WEI Jingxia.
One case of severe systemic rash caused by atorvastatin calcium tablets
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 939-942.
|
| [12] |
GUO Haiyan, HE Bo, YAN Hongli, YANG Xueting.
One case of persistent hiccup caused by Wenxin Keli
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 946-948.
|
| [13] |
SU Su, WU Shiqi, ZHANG Qingxia, YAN Suying.
Pharmaceutical care of a patient with indapamide-induced agranulocytosis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1282-1285.
|
| [14] |
YANG Caihua, YANG Longna, LI Xiaobo.
Two cases of fetal malformation after exposure to low dose warfarin sodium tablets in early pregnancy
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1286-1289.
|
| [15] |
ZHANG Wenwen, NIE Xiting, XU Huiru, RAN Ye, TIAN Chenglin, YU Shengyuan.
One case of extremely abnormal coagulation caused by warfarin combined with compound paracetamol and amantadine hydrochloride tablets
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1290-1292.
|
